ONC recently
released results from the
Coordinated Registry Network for Women’s Health Technologies project, a collaborative effort conducted with the U.S. Food and Drug Administration (FDA) and National Institutes of Health (NIH) to enable researchers to generate real-world evidence using data that address some women’s health issues.
The project’s final report discusses the findings and lessons learned from development and testing of the
Women’s Health Technologies Coordinated Registry Network FHIR® Implementation Guide.